Conference Proceedings

Cardioprotective effects of glucagon-like peptide 1 receptor agonists

Kardiologiya (2014) 54(7) 92-96
DOI: 10.18565/cardio.2014.7.92-96
7Citations
Citations of this article
22Readers
Mendeley users who have this article in their library.
Get full text

Abstract

In this paper we discuss pathogenetic mechanisms of cardiovascular risk reduction in patients with type 2 diabetes mellitus by glucagon-like peptide 1 (GLP-1) receptor agonists. Results of experimental studies and randomized clinical studies are presented, and perspectives for using GLP-1 agonists in patiente with diabetic cardiovascular complications are described.

Author supplied keywords

Cite

CITATION STYLE

APA

Ametov, A. S., Kamynina, L. L., & Akhmedova, Z. G. (2014). Cardioprotective effects of glucagon-like peptide 1 receptor agonists. In Kardiologiya (Vol. 54, pp. 92–96). Media Sphera Publishing Group. https://doi.org/10.18565/cardio.2014.7.92-96

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free